KEGG   DRUG: Tixagevimab and cilgavimab
Entry
D12262            Mixture   Drug                                   

Name
Tixagevimab and cilgavimab;
Evusheld (TN)
Product
  Other
Component
Tixagevimab [DR:D11993], Cilgavimab [DR:D11994]
Class
Antiviral
 DG03174  Anti-SARS-CoV-2 agent
Remark
ATC code: J06BD03
Product: D12262<US>
Efficacy
Antiviral
  Disease
Coronavirus disease 2019 [DS:H02398]
Comment
For the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19)
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J06 IMMUNE SERA AND IMMUNOGLOBULINS
   J06B IMMUNOGLOBULINS
    J06BD Antiviral monoclonal antibodies
     J06BD03 Tixagevimab and cilgavimab
      D12262  Tixagevimab and cilgavimab <US>
Drug groups [BR:br08330]
 Antiviral
  DG03174  Anti-SARS-CoV-2 agent
   D12262  Tixagevimab and cilgavimab
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12262
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12262
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system